Your browser doesn't support javascript.
loading
Comparison between Conventional Cytology and Liquid-Based Cytology in the Tertiary Brazilian Navy Hospital in Rio de Janeiro.
de Oliveira, Antônio Carlos Almeida; Domingues, Miguel Fontes; Neufeld, Paulo Murilo; Fleury, Marcos; Nogueira Neto, José Firmino.
Affiliation
  • de Oliveira ACA; Laboratory Medicine and Forensic Technology, Rio de Janeiro State University (UERJ), Rio de Janeiro, Brazil, antonio-carlos.almeida@marinha.mil.br.
  • Domingues MF; Hospital Naval Marcílio Dias, Pathology Service, Rio de Janeiro, Brazil, antonio-carlos.almeida@marinha.mil.br.
  • Neufeld PM; Hospital Naval Marcílio Dias, Pathology Service, Rio de Janeiro, Brazil.
  • Fleury M; Faculdade de Farmácia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
  • Nogueira Neto JF; Faculdade de Farmácia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Acta Cytol ; 64(6): 539-546, 2020.
Article in En | MEDLINE | ID: mdl-32516778
ABSTRACT

INTRODUCTION:

Cervical cancer screening is an important tool in public health. Liquid-based cytology (LBC) has been performed at the studied hospital for 7 years. The present study compares the performance of 2 LBC techniques with conventional cytology.

OBJECTIVE:

Our objective is to verify the sensitivity for the detection of neoplastic and preneoplastic epithelial atypia, as well as the positive predictive value of the 3 methodologies.

METHODS:

We analyzed retrospectively 24,529 cases and evaluated the conventional cytology, ThinPrep®, and BD SurePath® performance categorizing the results according to the Bethesda system. We also compared the level of unsatisfactory samples, the presence of elements from the squamocolumnar junction, and the detection of pathogenic microorganisms.

RESULTS:

ThinPrep® (1.43%) showed superior sensitivity over BD SurePath® (0.91%) and conventional cytology (0.71%) in terms of the detection of high-grade lesions; however, in terms of squamous atypia as a whole (ASC-US+), BD SurePath® (6.44%) proved to be more sensitive than conventional cytology (5.28%) and ThinPrep® (3.73%).

CONCLUSIONS:

The results show the advantage of implementing LBC in routine screening for cervical lesions. In this study, BD SurePath® achieved the overall best performance considering the studied variables.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Uterine Cervical Dysplasia / Uterine Cervical Neoplasms Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Adult / Female / Humans Country/Region as subject: America do norte / America do sul / Brasil Language: En Journal: Acta Cytol Year: 2020 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Uterine Cervical Dysplasia / Uterine Cervical Neoplasms Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Adult / Female / Humans Country/Region as subject: America do norte / America do sul / Brasil Language: En Journal: Acta Cytol Year: 2020 Document type: Article